Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Gastro Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Gastro Other
    Benefits of Bariatric Surgery in Adolescents Persist After 2 Years: Presented at AHA - (DGDispatch)
    Lubiprostone Approved in Switzerland for Chronic Idiopathic Constipation - (DGNews)
    FDA: Avoid Coadministration of Clopidogrel and Omeprazole, Esomeprazole - (DGNews)
    Autoimmune Gastritis May Be Underdiagnosed by as Much as Half: Presented at ASCP - (DGDispatch)
    Optical Techniques More Efficient Than Conventional Histopathology for Identifying Pre-Cancerous Polyps - (DGNews)

    News archive

     Recent webcasts/CME - Gastro Other
  • Applying Evidence to Improve Outcomes in Mild-to-Moderate Ulcerative Colitis: A Roundtable Discussion
  • Goals of Therapy for Mild-to-Moderate Ulcerative Colitis: What is Achievable?
  • Overcoming Obstacles in Mild-to-Moderate Ulcerative Colitis: Strategies for Better Adherence and Tolerability of First-Line Therapy
  • Carcinoid Tumors of the Gastrointestinal Tract

    Webcasts/CME archive

     Recent cases - Gastro Other
      Transient Anti-GAD Antibody Positivity and Acute Pancreatitis with Pancreas Tail Swelling in a Patient with Susceptible Haplotype for Type 1 Diabetes Mellitus
      Pancreatic Injury Successfully Treated with Endoscopic Stenting for Major Pancreatic Duct Disruption
      Jejuno-Jejunal Invagination Caused by Epithelioid Sarcoma: A Case Report
      Gastroparesis Associated with Gastroptosis Presenting as a Lower Abdominal Bulking Mass in a Child: A Case Report
      Renal Amyloidosis in Whipple Disease: A Case Report

      Cases archive
        




      my personal edition > gastro other > news
      divider

        E-Mail this DGDispatch to a colleague

      DGDispatch


      L-Arginine Application Speeds Healing of Anal Fissure: Presented at ASCRS

      By W. A. Thomasson
      Special to DG News

      CHICAGO, IL -- June 10, 2002 -- Topical application of a gel containing L-arginine 400 mg/mL promotes healing of chronic anal fissures, according to results of a small phase II study, presented Friday at the annual meeting of the American Society of Colon and Rectal Surgeons (ASCRS).

      The study was carried out and reported by M. Darby, MD, of University Hospital Dijkzigt in Rotterdam, Netherlands, and colleagues there and at Norgine Gmbh in Marburg, Germany.

      L-arginine is the natural precursor of nitric oxide (NO), the effects of which include relaxation of the anal sphincter. Topical application of artificial NO precursors, such as isosorbide dinitrate (ISDN), has been shown to promote fissure healing but is accompanied by frequent and sometimes severe headaches. The researchers hypothesized that because it is naturally present in the body, L-arginine might be free of headache risk.

      Fifteen patients (median age 36) were enrolled in the study. One patient dropped out of the study after a day, and one was excluded for protocol violation. The 13 evaluable patients had chronic anal fissures, and eight had previously been treated unsuccessfully with ISDN; five of the eight had experienced severe headache during ISDN treatment.
      Patients were treated with L-arginine gel for at least 12 weeks. Anal resting pressure decreased significantly after 12 weeks, from 89±17 to 74±14 mm Hg (p<0.005). There was likewise a significant increase in anodermal blood flow, from 0.36±0.25 to 0.64±0.33. Eight of the 13 fissures were healed and no patient had experienced headache after 12 weeks.

      These results indicate that topical application of L-arginine gel effectively promotes healing, even in patients who have not responded to other NO precursors. Furthermore, it does so without significant risk of headache. Precise details of efficacy and safety await larger studies, but these preliminary results are highly encouraging.



      E-Mail this DGDispatch to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send